Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03XOB
|
||||
| Former ID |
DNC014793
|
||||
| Drug Name |
5-hydroxymethylbenzo[b]thiophen-2-ylboronic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H7BO3S
|
||||
| Canonical SMILES |
B(C1=CC2=C(S1)C=CC(=C2)O)(O)O
|
||||
| InChI |
1S/C8H7BO3S/c10-6-1-2-7-5(3-6)4-8(13-7)9(11)12/h1-4,10-12H
|
||||
| InChIKey |
VDCIKADVYWVDGT-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 2007 Nov 15;50(23):5644-54. Epub 2007 Oct 23.Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.